Sun Pharma records turnaround Q2FY22 numbers, above estimates For the quarter ending September 2021, consolidated Net sales (including other operating income) of Sun Pharmaceuticals Industries has increased 12.54% to Rs 9625.93 crore compared to quarter ended september 2020. Operating profit margin has jumped from 25.64% to 27.32%, leading to 19.91% rise in operating profit to Rs 2,629.94 crore. Raw material cost as a % of total sales (net of stock...